Dimensional Fund Advisors’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-396,711
Closed -$3.74M – 3269
2026
Q2
$3.74M Buy
396,711
+384,864
+3,249% +$3.45M ﹤0.01% 2603
2026
Q1
$96.4K Buy
11,847
+689
+6% +$6.25K ﹤0.01% 3123
2025
Q4
$75K Buy
+11,158
New +$84.1K ﹤0.01% 3183
2022
Q3
– Sell
-10,513
Closed -$541K – 3514
2022
Q2
$541K Sell
10,513
-52,359
-83% -$2.71M ﹤0.01% 3047
2022
Q1
$4.63M Sell
62,872
-27,247
-30% -$2.43M ﹤0.01% 2558
2021
Q4
$12.9M Sell
90,119
-180
-0.2% -$30.9K ﹤0.01% 2200
2021
Q3
$18.7M Sell
90,299
-12,213
-12% -$2.69M 0.01% 2039
2021
Q2
$21.8M Buy
102,512
+7,553
+8% +$1.38M 0.01% 2014
2021
Q1
$17.2M Sell
94,959
-2,231
-2% -$445K 0.01% 2084
2020
Q4
$10.8M Buy
97,190
+5,090
+6% +$541K ﹤0.01% 2248
2020
Q3
$10M Buy
+92,100
New +$11.2M ﹤0.01% 2194
2015
Q4
– Sell
-15,272
Closed -$2.16M – 3339
2015
Q3
$2.16M Buy
+15,272
New +$3.42M ﹤0.01% 2795

Other funds holding NVAX

Dimensional Fund Advisors's NVAX Position: Q3 2026 in Review

Dimensional Fund Advisors sold out of Novavax (NVAX) in Q3 2026, closing a stake of 396,711 shares — an estimated $3.74M sold.

Dimensional Fund Advisors first reported a position in NVAX in Q3 2015 and held it in 12 quarters. The position peaked at $21.8M in Q2 2021. 259 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Dimensional Fund Advisors reported no remaining Novavax position as of Q3 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 396,711 Novavax shares in Q3 2026, an estimated $3.74M.
  • Dimensional Fund Advisors first reported a position in Novavax in Q3 2015 and held it in 12 quarters.
  • Dimensional Fund Advisors's Novavax position peaked at $21.8M in Q2 2021.
  • 259 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.